Immunophotonics is Drug Discovery in United States that focus on developer business. Founded in 2008. They cover business area such as developer, tumor ablation, hypnotherapy, cancer, tumor-associate neoantigen, situ, ablation-base immunogenic cell death, clinician.
2008
( 16 years old in 2024 )
Developer
-
4340 Duncan Avenue
Suite 212
Saint Louis, MO 63110
United States
Private
developertumor ablationhypnotherapycancertumor-associate neoantigensituablation-base immunogenic cell deathclinician
* We use standard office opening hours in near Immunophotonics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Immunophotonics is Drug Discovery business from United States that founded in 2008 (16 years old in 2024), Immunophotonics business is focusing on Developer.
Immunophotonics headquarter office and corporate office address is located in 4340 Duncan Avenue Suite 212 Saint Louis, MO 63110 United States.
Immunophotonics was founded in United States.
In 2024, Immunophotonics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Immunophotonics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
